Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,14,0.99 [0.77-1.26],0.914259172034578
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,14,0.92 [0.85-1.00],0.0437922561903433
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,14,0.96 [0.89-1.04],0.349852176635563
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,14,0.99 [0.86-1.14],0.837725678755029
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,14,0.98 [0.91-1.06],0.595749088362131
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,14,1.94 [0.88-4.29],0.102415409596224
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,14,1.03 [0.91-1.17],0.631649094152792
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,14,1.03 [0.29-3.63],0.960957894811933
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,14,0.95 [0.85-1.05],0.292175650757097
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,14,0.96 [0.77-1.21],0.737388837161935
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,14,1.22 [0.84-1.78],0.29898158521551
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,14,1.24 [0.88-1.75],0.211286465396792
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,14,0.96 [0.84-1.10],0.580435944876252
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,14,1.13 [0.64-1.99],0.683413120673888
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,14,0.93 [0.81-1.07],0.307993508432253
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,14,0.87 [0.77-0.98],0.0185699884895405
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,Inverse variance weighted,14,0.90 [0.67-1.22],0.510116718153867
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,14,1.00 [0.79-1.26],0.99099993937216
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,14,1.02 [0.83-1.25],0.838241935040204
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,14,1.02 [0.75-1.37],0.917351222090332
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,14,0.86 [0.47-1.56],0.61040848700295
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,14,0.98 [0.73-1.32],0.895150798614492
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,14,1.06 [0.81-1.38],0.670608077806882
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,14,0.81 [0.61-1.07],0.143819710148424
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,14,1.07 [0.82-1.40],0.618708072941288
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,14,1.07 [0.96-1.19],0.195514117068209
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",Inverse variance weighted,14,0.87 [0.66-1.14],0.313088768803328
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,14,0.93 [0.81-1.06],0.247969279716797
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,14,1.11 [0.87-1.43],0.406081181956711
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,14,0.79 [0.56-1.10],0.157171558198459
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,14,0.94 [0.83-1.06],0.337291665125345
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,14,1.05 [0.88-1.25],0.595178699974865
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,14,0.97 [0.78-1.21],0.781402511593086
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,14,0.96 [0.77-1.20],0.751355378762928
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,14,0.93 [0.85-1.00],0.0657012509033471
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,14,0.92 [0.86-0.98],0.0077357176938604
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,14,0.68 [0.24-1.90],0.457217131308342
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,14,0.85 [0.61-1.18],0.334831272730146
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,14,1.11 [0.94-1.30],0.220830353770141
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,14,1.31 [0.37-4.68],0.674906771629242
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,14,0.99 [0.89-1.11],0.911551230985715
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,14,0.57 [0.31-1.05],0.0698726259113788
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,14,1.11 [0.87-1.42],0.39984427267732
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,14,0.83 [0.62-1.10],0.184737706802509
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,14,0.93 [0.85-1.03],0.178823171609146
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,14,0.94 [0.86-1.03],0.184448822867598
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,14,1.00 [0.95-1.05],0.934407469595877
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,14,0.96 [0.75-1.24],0.779068913560644
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,14,0.99 [0.94-1.04],0.563807504594714
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,14,1.18 [0.82-1.69],0.371171292604955
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,14,0.99 [0.83-1.18],0.92012610585808
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,14,0.90 [0.75-1.08],0.25087506158037
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,14,1.02 [0.93-1.13],0.624344599887055
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,14,0.91 [0.83-1.00],0.0605806564638705
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,14,0.96 [0.87-1.07],0.474212312359462
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,14,1.11 [0.72-1.70],0.629837180661872
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,14,0.77 [0.49-1.20],0.250612652862487
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,14,0.93 [0.72-1.20],0.584369430151454
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,14,0.92 [0.83-1.03],0.158493176692188
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,14,0.93 [0.67-1.29],0.664723366085044
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,14,0.84 [0.63-1.11],0.223424331659658
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,14,0.93 [0.83-1.04],0.181065087925098
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,14,1.01 [0.88-1.15],0.927663897657396
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,14,0.96 [0.88-1.05],0.386165208985179
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,14,1.00 [0.92-1.09],0.932311236256883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,14,0.95 [0.78-1.15],0.578973368849958
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,14,0.96 [0.91-1.01],0.130777220252028
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,14,0.96 [0.91-1.02],0.229191971788979
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,14,1.58 [0.59-4.29],0.364664809463575
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,14,0.79 [0.53-1.18],0.246345338680781
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,14,0.96 [0.89-1.04],0.310288439775883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,14,0.95 [0.86-1.06],0.370566266497929
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,14,1.02 [0.76-1.37],0.890119863397959
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,14,0.97 [0.86-1.09],0.586419177748075
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,14,0.90 [0.83-0.99],0.0222907056865599
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,14,0.95 [0.68-1.33],0.759334507378943
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,14,1.15 [0.74-1.76],0.538957504283547
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,14,0.65 [0.49-0.86],0.0029981977406305
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,14,0.95 [0.82-1.11],0.522523748410568
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,14,1.47 [0.94-2.31],0.093157235717564
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,14,1.82 [1.13-2.95],0.0140154157308776
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,14,0.86 [0.54-1.38],0.537542190805648
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,14,0.94 [0.83-1.06],0.292096181903591
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,14,0.93 [0.86-1.02],0.111310050319018
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,14,1.48 [0.99-2.20],0.0553649021235346
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,14,0.91 [0.75-1.09],0.30457379271503
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,14,0.97 [0.90-1.04],0.381162425896883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,14,0.89 [0.66-1.19],0.427222942620082
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,14,1.03 [0.82-1.29],0.818438941912758
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,14,0.96 [0.91-1.02],0.191547840063093
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,14,0.95 [0.90-1.00],0.0733122558158897
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,14,0.96 [0.86-1.07],0.446576549923304
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,14,1.00 [0.90-1.11],0.97710666328271
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,14,0.99 [0.81-1.20],0.900124561837524
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,14,0.92 [0.70-1.20],0.526482450612372
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,14,0.98 [0.90-1.07],0.66189551415361
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,14,1.04 [0.80-1.35],0.778887774568832
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,14,1.03 [0.96-1.11],0.378116849989987
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,14,0.83 [0.65-1.07],0.147595234714416
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,14,1.05 [0.93-1.18],0.413967335213805
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,14,1.03 [0.73-1.46],0.849441889879438
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,14,0.74 [0.49-1.12],0.15030631113515
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,14,0.95 [0.90-1.01],0.0822630606452904
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,14,0.91 [0.78-1.07],0.247220841047653
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,14,0.97 [0.91-1.04],0.452355205150901
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,14,0.91 [0.66-1.26],0.57569212037889
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,14,1.15 [1.00-1.33],0.0504830750667901
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,14,0.91 [0.83-1.01],0.0868970036222955
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,14,0.99 [0.79-1.24],0.925736400171773
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,14,0.95 [0.71-1.28],0.744480436949156
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",Inverse variance weighted,14,0.91 [0.85-0.98],0.0104883718797508
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,14,0.96 [0.91-1.01],0.0914563279245244
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,14,0.88 [0.78-1.00],0.0496860129970448
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,14,0.87 [0.74-1.02],0.0810156297203452
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,14,0.99 [0.66-1.47],0.941327456615275
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,14,0.94 [0.86-1.02],0.155354366148683
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,Inverse variance weighted,14,1.07 [0.77-1.49],0.693925542634105
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,14,0.94 [0.86-1.03],0.191426049350332
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,14,0.79 [0.64-0.97],0.0278688143160934
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,14,1.00 [0.94-1.06],0.969127331460998
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,14,1.03 [0.94-1.12],0.593987487280218
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,14,1.03 [0.92-1.15],0.59427279245253
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,14,0.94 [0.89-0.99],0.0175526975917571
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,14,0.90 [0.77-1.06],0.225309426513337
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,14,1.01 [0.92-1.11],0.810020621788063
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,14,1.05 [0.90-1.22],0.508949062206314
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,14,0.99 [0.90-1.08],0.798596724532873
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,14,1.04 [0.88-1.23],0.649008776718479
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],Inverse variance weighted,14,1.14 [0.85-1.52],0.384927668966874
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,14,0.99 [0.94-1.05],0.724534369768479
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,14,0.87 [0.62-1.21],0.400059876004567
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,14,0.97 [0.89-1.06],0.531726363288718
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,Inverse variance weighted,14,0.91 [0.81-1.01],0.0880849006241001
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,14,1.01 [0.85-1.19],0.914671124013504
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,14,0.97 [0.66-1.42],0.871546987845091
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,14,1.08 [0.94-1.23],0.301232952429748
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,14,1.08 [0.72-1.62],0.697288563026366
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,14,1.05 [0.84-1.31],0.682376254561901
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,14,0.92 [0.74-1.15],0.482210391382749
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,14,0.90 [0.69-1.18],0.444539259062517
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,14,0.99 [0.64-1.52],0.949315031754388
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,14,1.02 [0.95-1.11],0.56955036295291
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,14,0.96 [0.74-1.23],0.723549431246674
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,14,1.02 [0.94-1.10],0.614205241348603
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,14,1.02 [0.95-1.09],0.616717031016051
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,14,0.74 [0.57-0.98],0.0334193776537565
